WEN Lu, OUYANG Hui, YUAN Hao, TIAN Jing, ZHANG Fang. Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 46-50. DOI: 10.7619/jcmp.20222662
Citation: WEN Lu, OUYANG Hui, YUAN Hao, TIAN Jing, ZHANG Fang. Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 46-50. DOI: 10.7619/jcmp.20222662

Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention

More Information
  • Received Date: August 25, 2022
  • Available Online: January 06, 2023
  • Objective 

    To analyze the correlations of serum B-type brain natriuretic peptide (BNP) with arterial partial pressure of oxygen[pa(O2)], high-sensitivity C-reactive protein (hs-CRP), right ventricular end diastolic diameter (RVDD) and death in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and left ventricular ejection function (LVEF) preservation.

    Methods 

    The data of 150 AECOPD patients with LVEF preservation were retrospectively analyzed. According to the serum BNP level, they were divided into group A (BNP ≤ 100 pg/mL, n=82), group B (BNP>100 pg/mL to 400 pg/mL, n=45) and group C (BNP>400 pg/mL, n=23). The pa(O2), BNP, hs-CRP and RVDD were compared among the three groups after admission. The correlations of BNP with pa(O2), hs-CRP as well as RVDD were analyzed; predictors of death within 1 year were analyzed by Logistic regression. The 1 year mortality risk ratio (RR) of the 3 groups was analyzed.

    Results 

    The pa(O2) in group B and group C was significantly lower than that in group A, and BNP, hs-CRP and RVDD were higher than those in group A (P < 0.05). BNP and hs-CRP in group C were significantly higher than those in group B (P < 0.05). Correlation analysis showed that BNP was negatively correlated with pa(O2) (r=-0.385, P < 0.001), but positively correlated with hs-CRP and RVDD (r=0.664, 0.388, P < 0.001). Within 1 year, the RR and 95%CI of group C with group A and group B were 1.303(1.019 to 1.668) and 1.263(0.978 to 1.630), respectively, and the differences were statistically significant (P < 0.05). BNP was an independent predicting factor for death within 1 year (P < 0.05).

    Conclusion 

    The elevated BNP level in AECOPD patients with LVEF preservation is associated with decreased pa(O2) level, increased hs-CRP, and increased RVDD. Serum BNP is a sensitive indicator for assessing the condition of AECOPD and death.

  • [1]
    YU S S, ZHANG J, FANG Q H, et al. Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Am J Med Sci, 2021, 362(1): 56-62. doi: 10.1016/j.amjms.2021.02.013
    [2]
    MAISE A, MUELLER C, PEACOCK W F, et al. 2008中西方BNP专家共识[J]. 中国医药导刊, 2009, 11(10): 1628-1637. doi: 10.3969/j.issn.1009-0959.2009.10.003
    [3]
    ABROUG F, OUANES-BESBES L, NCIRI N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers[J]. Am J Respir Crit Care Med, 2006, 174(9): 990-996. doi: 10.1164/rccm.200603-380OC
    [4]
    中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会, 陈荣昌, 等. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. doi: 10.3760/cma.j.cn112147-20210109-00031
    [5]
    YAO C, WANG L W, SHI F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure[J]. Int J Med Sci, 2021, 18(7): 1592-1599. doi: 10.7150/ijms.52405
    [6]
    吕骁, 张宏英, 毛雅云, 等. BNP、HCAR及D-D在慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭中的变化及与病情、预后的相关性[J]. 临床误诊误治, 2021, 34(6): 86-91. doi: 10.3969/j.issn.1002-3429.2021.06.018
    [7]
    王宝俊, 王华, 张金莲. 慢性阻塞性肺疾病急性加重期患者血浆中肌钙蛋白Ⅰ、脑钠肽及血尿酸测定的临床意义[J]. 国际呼吸杂志, 2016, 36(16): 1225-1227. doi: 10.3760/cma.j.issn.1673-436X.2016.16.006
    [8]
    NISHIMURA K, NISHIMURA T, ONISHI K, et al. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 155-162.
    [9]
    HAWKINS N M, KHOSLA A, VIRANI S A, et al. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review[J]. BMC Pulm Med, 2017, 17(1): 11. doi: 10.1186/s12890-016-0345-7
    [10]
    王煜. 慢性阻塞性肺疾病中脑钠肽水平的变化及其临床意义[J]. 陕西医学杂志, 2013, 42(1): 18-20. doi: 10.3969/j.issn.1000-7377.2013.01.005
    [11]
    胡旭, 靳开宇, 范贤明. 慢性阻塞性肺疾病合并支气管扩张的发病机制、诊断与治疗研究进展[J]. 山东医药, 2016, 56(31): 106-108. doi: 10.3969/j.issn.1002-266X.2016.31.036
    [12]
    廉静, 张爱菊, 张燕. 超敏C反应蛋白与扩张型心肌病患者炎症因子水平、心功能的相关性[J]. 心血管康复医学杂志, 2018, 27(6): 642-645. doi: 10.3969/j.issn.1008-0074.2018.06.07
    [13]
    吴长东, 侯铭, 杨嵘, 等. 联合检测二维超声心动图、BNP、6MWT、MMRC对慢性阻塞性肺疾病急性加重期患者右心功能不全的诊断意义[J]. 中华肺部疾病杂志: 电子版, 2019, 12(4): 441-444. doi: 10.3877/cma.j.issn.1674-6902.2019.04.008
    [14]
    王潇, 许爱国. 频繁急性加重的慢性阻塞性肺疾病继发肺动脉高压的危险因素分析[J]. 河南医学研究, 2020, 29(31): 5782-5785. doi: 10.3969/j.issn.1004-437X.2020.31.006
    [15]
    MAO B, LU H W, LI M H, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD[J]. Sci Rep, 2015, 5: 10961. doi: 10.1038/srep10961
    [16]
    PARK S Y, LEE C Y, KIM C, et al. One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonale[J]. J Korean Med Sci, 2015, 30(4): 442-449. doi: 10.3346/jkms.2015.30.4.442
    [17]
    赵娜, 谢才德. 血浆B型脑钠肽水平在慢性阻塞性肺疾病近远期治疗预后评估中的价值[J]. 临床肺科杂志, 2017, 22(3): 427-430. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK201703011.htm
    [18]
    谢小兵, 高云, 牛灵, 等. 急性加重期和稳定期COPD患者血清CRP、IL-6、PCT及BNP水平变化[J]. 山东医药, 2020, 60(30): 73-75. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202030019.htm
  • Related Articles

    [1]HOU Bingbing, MA Yin, WANG Wei, YANG Xiaoxin, GAO Yan. Application effect of multidisciplinary collaborative nursing based on the Information-Knowledge-Attitude-Practice theory in patients undergoing lobectomy via thoracoscopy[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 89-93. DOI: 10.7619/jcmp.20245219
    [2]LU Yanfeng, DAI Jiabao, WU Zhouquan, ZOU Zhiqing. Effect of esketamine on perioperative pain and depression in patients with thoracoscopic pulmonary nodule resection[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 90-94. DOI: 10.7619/jcmp.20234042
    [3]WEI Xinqi, RUAN Aichao, YANG Ying, ZHANG Qing. Clinical nursing pathway management in patients with CT-guided thoracoscopic small pulmonary nodules resection[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 120-123. DOI: 10.7619/jcmp.20221144
    [4]Palidan·NIYAZI, Yisilamujiang·TUERXUN, WANG Shanshan. Application value of Hook-wire localization under CT guidance before thoracoscopic resection of small pulmonary ground-glass nodules[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 36-39, 44. DOI: 10.7619/jcmp.20221137
    [5]WANG Jianping, GAO Jie, XUE Hengchuan, MA Zhenkai, ZHU Zonghai, ZHAO Mengmeng. Thoracoscopic pulmonary segmentectomy versus lobectomy in the treatment of early non-small cell lung cancer in elderly patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 97-100. DOI: 10.7619/jcmp.202011026
    [6]LIN Zhizhong, YU Wei, TUO Zhe, HU Xiuhua. Thoracoscope-assisted small incision surgery versus traditional thoracotomy in the treatment of pulmonary bulla patients complicated with spontaneous pneumothorax[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 88-91. DOI: 10.7619/jcmp.202001022
    [7]XU Yi, CUI Fengxian, ZHANG Shaofen, GUO Jun, PENG Jun. Analysis of fast comprehensive rehabilitation care for single hole thoracoscopic pulmonary lobectomy in patients in perioperation[J]. Journal of Clinical Medicine in Practice, 2017, (14): 75-77. DOI: 10.7619/jcmp.201714022
    [8]ZHENG Congchong, YU Tongfu, LIU Xisheng, CHEN Liang, ZHU Quan, XU Hai, ZHANG Wei. Application of preoperative CT-guided Hookwire and methylxanthine chloride in treatment of small pulmonary nodule patients with thoracoscopy[J]. Journal of Clinical Medicine in Practice, 2014, (3): 33-35. DOI: 10.7619/jcmp.201403010
    [9]Lu Ye, Cheng Hui, Chen Yong. Perioperative nursing for patients with thoracoscopic resection of lung bullae[J]. Journal of Clinical Medicine in Practice, 2012, (22): 166-167,172.
    [10]ZHANG Qing-hai, HUANG Li-li, WANG Xin. Postoperative analgesia effect of propacetamol on pulmonary bulla resection by thoracoscopy[J]. Journal of Clinical Medicine in Practice, 2012, (17): 119-120,123.
  • Cited by

    Periodical cited type(35)

    1. 卢新阳,孙奕舒,徐涛,范龙彬,常雅宁,周英骏. 玫瑰蜂花粉破壁工艺优化及其醇提物生理活性比较. 食品工业科技. 2025(04): 176-184 .
    2. 彭展. 前列舒通胶囊联合坦索罗辛治疗轻度良性前列腺增生患者的效果. 中国民康医学. 2024(05): 106-109 .
    3. 马嘉,邢建月,张宇鹏,刘光珍. 中成药治疗良性前列腺增生有效性和安全性的贝叶斯网状Meta分析. 药物流行病学杂志. 2024(03): 301-318 .
    4. 凡丽丽,任贤,赵会云. 腕踝针镇痛对老年患者经尿道前列腺等离子电切术后膀胱痉挛及康复效果的影响. 深圳中西医结合杂志. 2024(07): 46-48 .
    5. 王红慧,姚华婧,王本鹏. 基于网络药理学及分子对接探讨灵泽片治疗前列腺良性增生的作用机制. 中医临床研究. 2024(20): 7-14 .
    6. 张秋燕,张恋. 基于加速康复外科理念的护理在良性前列腺增生患者围手术期中的应用效果分析. 延边大学医学学报. 2024(05): 652-655 .
    7. 赵锦燕,王雪皎,李斐,林久茂,周建衡. 前列宁调控基质金属蛋白酶降解胶原蛋白对前列腺增生治疗的影响. 世界中医药. 2024(22): 3467-3472+3478 .
    8. 张文武,梁美丹,李峰. 中西医结合治疗良性前列腺增生研究进展. 辽宁中医药大学学报. 2023(01): 216-220 .
    9. 米嘉希,陈慧,曹璐,朱冠辰. 基于加速康复外科理念的护理在良性前列腺增生患者围术期中的应用. 护理实践与研究. 2023(01): 6-10 .
    10. 黄瑜,蔡润东,李军. 小蓟饮子治疗良性前列腺增生患者经尿道前列腺切除术后出血的疗效. 中国民间疗法. 2023(03): 60-63 .
    11. 杨硕,谢雁鸣,王连心,孙粼希. 夏荔芪胶囊治疗前列腺增生(本虚标实证)的临床综合评价. 中草药. 2023(09): 2879-2888 .
    12. 张志忠. 前列腺汽化电切术治疗前列腺增生合并慢性前列腺炎的效果及其对炎症因子、尿动力学的影响. 黑龙江医学. 2023(08): 925-928 .
    13. 朱媛媛,边利萍. 手术室预见性干预结合舒适性护理对前列腺增生手术患者压力性损伤及应激反应的影响. 临床医学研究与实践. 2023(13): 150-152 .
    14. 曹艳敏,梁敬哲,李馨悦,王丹妮,董梦薇,何立. 督脉药饼灸法治疗肾虚血瘀型良性前列腺增生的临床研究. 河北中医药学报. 2023(03): 25-28+34 .
    15. 吴崇才,林鸿彪. PKURP术联合同期行TEP对老年前列腺增生合并腹股沟疝治疗的效果. 中国老年学杂志. 2023(13): 3152-3155 .
    16. 贾玉聪,张辉,张凯波,樊立鹏,陈翔,郝高利,付晓君. 针刺联合益肾通络督脉灸治疗良性前列腺增生. 中医学报. 2023(08): 1783-1787 .
    17. 梁博,商学军,裴丽君. 中国中老年男性人群患慢性疾病与可能肌少症发生风险关联的队列研究. 中华男科学杂志. 2023(01): 10-18 .
    18. 于楠楠,刘征,匡禹霏,韩亚鹏,薛剑,李禹洋,孙殿甲. 热敏灸结合芒针透刺对良性前列腺增生症尿动力学、血中激素及PSA水平影响的临床研究. 针灸临床杂志. 2023(08): 38-42 .
    19. 王鹏,熊伟,龙衍,周青. 周青基于“肺为水之上源”论治男性下尿路症状经验. 中医药导报. 2023(08): 193-197 .
    20. 杨周,李健,陈治宇,张文雯,胡霞,于朝春. 五苓散在膀胱功能障碍相关疾病中的临床应用进展. 世界中西医结合杂志. 2023(08): 1692-1696 .
    21. 尹晓艳,习小燕,周晓兰. 综合性护理应用于前列腺电切术病人的效果评价. 现代诊断与治疗. 2023(13): 2029-2031 .
    22. 周建衡,赵锦燕,王雪皎,李斐,林久茂. 前列宁通过调控前列腺MMP-2、TIMP-2降解层粘连蛋白治疗良性前列腺增生的机制研究. 福建中医药. 2023(09): 51-55 .
    23. 李风. 六味南术汤治疗前列腺增生症临床观察. 中国中医药现代远程教育. 2023(24): 97-99 .
    24. 韩亮,王彬,张新荣,彭爱进,杨勇,李海松,张霄潇. 良性前列腺增生实验模型述评. 中国实验方剂学杂志. 2022(02): 227-235 .
    25. 孙粼希,吕健,谢雁鸣. 夏荔芪胶囊治疗良性前列腺增生的有效性和安全性的Meta分析. 中药新药与临床药理. 2022(02): 265-272 .
    26. 朱文雄,袁轶峰,彭涛,张熙,刘涛,李博,陈其华. 益气活血消癥方干预TFF/Wnt信号通路治疗前列腺增生的研究. 北京中医药大学学报. 2022(02): 193-200 .
    27. 张强,杨晓亮,杨晓波,师宏斌,赵瑞宁,张超. CD71与E-cadherin在丙酸睾酮诱导的前列腺组织中的表达. 宁夏医学杂志. 2022(04): 319-321+385 .
    28. 于国盛,杨波,王成达,郝战宽. 两种手术方式治疗大体积良性前列腺增生症效果比较. 中国实用乡村医生杂志. 2022(04): 47-49+53 .
    29. 马允,侯冰燕,张志,刘颖,王文地,侯俊玲,王文全. 不同龄SD大鼠自发性良性前列腺增生的研究. 西北药学杂志. 2022(03): 112-116 .
    30. 张凯波,李桓,王锁刚. 基于网络药理学及分子对接技术研究五苓散治疗前列腺增生的作用机制. 中医学报. 2022(08): 1727-1733 .
    31. 刘尧,赵永哲,赵伟,贺迎雪,李乘龙,张雷,冯士楼. 经尿道前列腺钬激光剜除术对良性前列腺增生患者的影响. 中外医学研究. 2022(20): 33-38 .
    32. 项效益. 前列腺动脉栓塞术联合经尿道前列腺电切术治疗体积>80 ml良性前列腺增生的短中期随访研究. 临床医学. 2022(09): 22-25 .
    33. 王皓,冯岳龙,杨玲,张强,高裕,李培军. ALDH2在丙酸睾酮诱导的前列腺组织中的表达. 宁夏医学杂志. 2022(11): 968-969+956 .
    34. 王琳琳,许丽丽,范君,钱余. 氧化应激标志物与前列腺增生和前列腺癌的相关性. 检验医学. 2022(12): 1135-1140 .
    35. 郝梦,米尔扎提·麦麦提,马璇,张明惠,季志红. 基于网络药理学和分子对接探讨西帕依麦孜彼子口服液抗良性前列腺增生的作用机制. 中国药师. 2021(12): 2148-2153+2166 .

    Other cited types(20)

Catalog

    Article views (195) PDF downloads (14) Cited by(55)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return